![](/img/cover-not-exists.png)
O3-04-01: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month multi-center phase 3 trial
Robert C. Green, Lon S. Schneider, Suzanne B. Hendrix, Kenton H. Zavitz, Edward SwabbVolume:
4
Year:
2008
Language:
english
DOI:
10.1016/j.jalz.2008.05.432
File:
PDF, 55 KB
english, 2008